148 related articles for article (PubMed ID: 11746184)
21. Effects of meso-2,3-dimercaptosuccinic acid, potassium iodide and chlorophyll on lead accumulation in male mice.
Xie Y; Zhou G
Int J Occup Med Environ Health; 2017 Feb; 30(1):87-93. PubMed ID: 28220909
[TBL] [Abstract][Full Text] [Related]
22. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
23. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
Aslani MR; Najarnezhad V; Mohri M
Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities.
Sivaprasad TR; Malarkodi SP; Varalakshmi P
Chem Biol Interact; 2004 Apr; 147(3):259-71. PubMed ID: 15135082
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
26. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism.
Malvezzi CK; Moreira EG; Vassilieff I; Vassilieff VS; Cordellini S
Braz J Med Biol Res; 2001 Oct; 34(10):1341-6. PubMed ID: 11593311
[TBL] [Abstract][Full Text] [Related]
27. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
28. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
29. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
Glotzer DE
Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
[TBL] [Abstract][Full Text] [Related]
30. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats.
Flora SJ
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):865-9. PubMed ID: 10561806
[TBL] [Abstract][Full Text] [Related]
31. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
Flora SJ; Kannan GM; Pant BP; Jaiswal DK
Arch Toxicol; 2002 Jun; 76(5-6):269-76. PubMed ID: 12107644
[TBL] [Abstract][Full Text] [Related]
32. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
Haust HL; Inwood M; Spence JD; Poon HC; Peter F
Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
[TBL] [Abstract][Full Text] [Related]
34. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
35. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
36. Impacts of lead exposure and chelation therapy on bone metabolism during different developmental stages of rats.
Zhang Y; Zhou L; Li S; Liu J; Sun S; Ji X; Yan C; Xu J
Ecotoxicol Environ Saf; 2019 Nov; 183():109441. PubMed ID: 31404725
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of edetate calcium disodium and dimercaptosuccinic acid in the treatment of lead poisoning in adults.
Sakthithasan K; Lévy P; Poupon J; Garnier R
Clin Toxicol (Phila); 2018 Nov; 56(11):1143-1149. PubMed ID: 29889577
[TBL] [Abstract][Full Text] [Related]
38. Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning.
Fang X; Fernando Q
Chem Res Toxicol; 1995 Jun; 8(4):525-36. PubMed ID: 7548732
[TBL] [Abstract][Full Text] [Related]
39. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
40. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
